2-175080764-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001880.4(ATF2):c.1187G>A(p.Ser396Asn) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,611,248 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001880.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATF2 | NM_001880.4 | c.1187G>A | p.Ser396Asn | missense_variant, splice_region_variant | 13/14 | ENST00000264110.7 | NP_001871.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATF2 | ENST00000264110.7 | c.1187G>A | p.Ser396Asn | missense_variant, splice_region_variant | 13/14 | 1 | NM_001880.4 | ENSP00000264110.2 |
Frequencies
GnomAD3 genomes AF: 0.0000331 AC: 5AN: 151244Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000802 AC: 2AN: 249486Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134846
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1460004Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 726342
GnomAD4 genome AF: 0.0000331 AC: 5AN: 151244Hom.: 0 Cov.: 32 AF XY: 0.0000271 AC XY: 2AN XY: 73874
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 30, 2024 | The c.1187G>A (p.S396N) alteration is located in exon 13 (coding exon 11) of the ATF2 gene. This alteration results from a G to A substitution at nucleotide position 1187, causing the serine (S) at amino acid position 396 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at